Charcot–Marie–Tooth disease (CMT) and associated neuropathies are the most predominant genetically transmitted neuromuscular conditions; however, effective pharmacological treatments have not established. The extensive genetic heterogeneity of CMT, which impacts peripheral nerves causes lifelong disability, presents a significant barrier to development comprehensive treatments. An estimated 100...